Cargando…
Development of TIMP1 magnetic nanoformulation for regulation of synaptic plasticity in HIV-1 infection
Although the introduction of antiretroviral therapy has reduced the prevalence of severe forms of neurocognitive disorders, human immunodeficiency virus (HIV)-1-associated neurocognitive disorders were observed in 50% of HIV-infected patients globally. The blood–brain barrier is known to be impermea...
Autores principales: | Atluri, Venkata Subba Rao, Jayant, Rahul Dev, Pilakka-Kanthikeel, Sudheesh, Garcia, Gabriella, Samikkannu, Thangavel, Yndart, Adriana, Kaushik, Ajeet, Nair, Madhavan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012635/ https://www.ncbi.nlm.nih.gov/pubmed/27621622 http://dx.doi.org/10.2147/IJN.S108329 |
Ejemplares similares
-
Effect of Cocaine on HIV Infection and Inflammasome Gene Expression Profile in HIV Infected Macrophages
por: Atluri, Venkata Subba Rao, et al.
Publicado: (2016) -
Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse
por: Sagar, Vidya, et al.
Publicado: (2016) -
Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder
por: Atluri, Venkata Subba Rao, et al.
Publicado: (2014) -
Human Synaptic Plasticity Gene Expression Profile and Dendritic Spine Density Changes in HIV-Infected Human CNS Cells: Role in HIV-Associated Neurocognitive Disorders (HAND)
por: Atluri, Venkata Subba Rao, et al.
Publicado: (2013) -
Targeted Brain Derived Neurotropic Factors (BDNF) Delivery across the Blood-Brain Barrier for Neuro-Protection Using Magnetic Nano Carriers: An In-Vitro Study
por: Pilakka-Kanthikeel, Sudheesh, et al.
Publicado: (2013)